Kush Parmar, 10% Owner, Director, on July 30, 2026, sold 116,474 shares in Entrada Therapeutics (TRDA) for $807,027. Following the Form 4 filing with the SEC, Parmar has control over a total of 3,939,905 common shares of the company, with 3,939,905 controlled indirectly.
SEC Filing: